Hybrigenics offers a bioinformatics platforms to identify;validate;and inhibit protein interactions to develop therapeutics for cancer.
Hybrigenics has raised €13M across 2 funding rounds, most recently a round in Aug 2017. Based in Paris, France; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2017-08-01 | Other | €6.8M | — | View deal → |
| 2009-09-01 | Other | €6.6M | — | View deal → |
